Advances in neonatal care have lead to significant improvement in survival and quality of life in newborn infants. The extremely preterm neonates, i.e. newborns of 23-27 weeks of gestational age, have the highest risk of developing severe multi-organ failure and death.
The purpose of this Research Topic is to focus on the best strategies to help extremely premature infants, the most vulnerable class of babies, adapt to postnatal life. On the basis of the best available evidence, the management of respiratory, cardiovascular and gastrointestinal insufficiency will be discussed. The role of new technologies and strategies to successfully use non-invasive respiratory support, surfactant and newborn feeding, bronchopulmonary dysplasia prevention, necrotizing enterocolitis, infection and neurological disorders will also be evaluated.
This article collection is envisaged to address, but not be limited to, the following thematic areas:
1. Non-invasive monitoring strategies (e.g. continuous glucose monitoring, NIRS)
2. Non-invasive respiratory support
3. New techniques of surfactant administration (LISA, IN-REC-SUR-E)
4. Strategies for the prevention of bronchopulmonary dysplasia
5. Management of feeding disorders
6. Strategies for the prevention necrotizing enterocolitis (e.g. use of probiotic, antibiotic stewardship)
7. Strategies for the prevention of infections (e.g. surveillance microbial cultures, management of central infusion lines, use of probiotics)
8. Central nervous system protection strategies
9. Comfort care strategies.
Advances in neonatal care have lead to significant improvement in survival and quality of life in newborn infants. The extremely preterm neonates, i.e. newborns of 23-27 weeks of gestational age, have the highest risk of developing severe multi-organ failure and death.
The purpose of this Research Topic is to focus on the best strategies to help extremely premature infants, the most vulnerable class of babies, adapt to postnatal life. On the basis of the best available evidence, the management of respiratory, cardiovascular and gastrointestinal insufficiency will be discussed. The role of new technologies and strategies to successfully use non-invasive respiratory support, surfactant and newborn feeding, bronchopulmonary dysplasia prevention, necrotizing enterocolitis, infection and neurological disorders will also be evaluated.
This article collection is envisaged to address, but not be limited to, the following thematic areas:
1. Non-invasive monitoring strategies (e.g. continuous glucose monitoring, NIRS)
2. Non-invasive respiratory support
3. New techniques of surfactant administration (LISA, IN-REC-SUR-E)
4. Strategies for the prevention of bronchopulmonary dysplasia
5. Management of feeding disorders
6. Strategies for the prevention necrotizing enterocolitis (e.g. use of probiotic, antibiotic stewardship)
7. Strategies for the prevention of infections (e.g. surveillance microbial cultures, management of central infusion lines, use of probiotics)
8. Central nervous system protection strategies
9. Comfort care strategies.